Olema Pharmaceuticals, Inc. (OLMA)
6.99
-0.34
(-4.64%)
USD |
NASDAQ |
Oct 30, 16:00
6.99
0.00 (0.00%)
After-Hours: 18:09
Olema Pharmaceuticals Cash and Short Term Investments (Annual) : 505.44M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 505.44M |
| December 31, 2024 | 434.09M |
| December 31, 2023 | 261.81M |
| December 31, 2022 | 204.42M |
| Date | Value |
|---|---|
| December 31, 2021 | 287.25M |
| December 31, 2020 | 338.55M |
| December 31, 2019 | 0.068M |
| December 31, 2018 | 3.149M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Puma Biotechnology, Inc. | 99.62M |
| SELLAS Life Sciences Group, Inc. | 71.89M |
| ACADIA Pharmaceuticals, Inc. | 819.69M |
| Alnylam Pharmaceuticals, Inc. | 2.908B |
| Anika Therapeutics, Inc. | 57.48M |